Correction to: Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration (International Journal of Clinical Oncology, (2019), 24, 5, (546-553), 10.1007/s10147-018-01388-5)

Keisuke Shigeta, Takeo Kosaka, Hiroshi Hongo, Yoshinori Yanai, Kazuhiro Matsumoto, Shinya Morita, Ryuichi Mizuno, Toshiaki Shinojima, Eiji Kikuchi, Mototsugu Oya

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the Original Publication, Tables 2 and 3 have been published with “###” instead of numerical values. Also in Table 2, few entries were inadvertently published in bold. The corrected tables are given in this Correction. The errors have been occurred at Publisher’s end. The original article has been corrected.

Original languageEnglish
Pages (from-to)554-556
Number of pages3
JournalInternational Journal of Clinical Oncology
Volume24
Issue number5
DOIs
Publication statusPublished - 2019 May 15

ASJC Scopus subject areas

  • Surgery
  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Correction to: Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration (International Journal of Clinical Oncology, (2019), 24, 5, (546-553), 10.1007/s10147-018-01388-5)'. Together they form a unique fingerprint.

Cite this